Kwong Yok Lam

  • Fellowship in 1987 at The Royal Marsden Hospital

Professor Kwong is chief of the Division of Haemaotlogy, Medical Oncology and Bone Marrow Transplantation at the Department of Medicine, University of Hong Kong, and director of the haematopoietic stem cell transplantation centre at Queen Mary Hospital. He is a chair professor, and holds the Chui Fook Chuen Professor in Molecular Medicine. He is specialized in haematology and haematopahtology. His clinical work focuses on the management of haematological malignancies. His research  centers on the molecular pathogenetic pathways and novel treatment modalities in haematological neoplasms. Together with the clinical pharamacology team in his department, Professor Kwong has pioneered the development and use of oral arsenic trioxide in the treatment of acute promyelocytic leukaemia and other blood cancers. The oral arsenic troxide formulation has successfully secured patents in the United States of America and Japan. His research team is also actively involved in defining the molecular defects and optimal treatment protocols for T-cell and natural killer cell lymphomas, which are neoplasms prevalent in Asian populations


1. Leukaemia treatment and research

2. Lymphoma treatment and research

3. Treatment and  research in solid tumours